
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
Issues like medication access and transportation cost all impact a patient's ability to have access to medications and use them safely and effectively.
Pharmacy Times spoke with Richard Schmitz, PQA Chief Engagement Officer, about how social determinants of health (SDOH) fits with PQA’s work to improve medication safety and appropriate use.
Schmitz: Well SDOH is a priority for PQA because issues like medication access, transportation cost, all impact a patient's ability to have access to medications and use them safely and effectively.





